U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hemorrhoids, CTCAE_3

MedGen UID:
368414
•Concept ID:
C1963134
•
Finding

Recent clinical studies

Etiology

Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
Meixner E, Wark A, Forster T, Weykamp F, Lang K, König L, Lindel K, Oelmann-Avendano JT, Krisam J, Schneeweiss A, Ellerbrock M, Mielke T, Hörner-Rieber J, Herfarth K, Debus J, Arians N
Radiat Oncol 2023 Jan 9;18(1):5. doi: 10.1186/s13014-023-02198-4. PMID: 36624483Free PMC Article
Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon.
Deville C, Both S, Bui V, Hwang WT, Tan KS, Schaer M, Tochner Z, Vapiwala N
Radiat Oncol 2012 May 23;7:76. doi: 10.1186/1748-717X-7-76. PMID: 22621764Free PMC Article

Therapy

Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
Meixner E, Wark A, Forster T, Weykamp F, Lang K, König L, Lindel K, Oelmann-Avendano JT, Krisam J, Schneeweiss A, Ellerbrock M, Mielke T, Hörner-Rieber J, Herfarth K, Debus J, Arians N
Radiat Oncol 2023 Jan 9;18(1):5. doi: 10.1186/s13014-023-02198-4. PMID: 36624483Free PMC Article
Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon.
Deville C, Both S, Bui V, Hwang WT, Tan KS, Schaer M, Tochner Z, Vapiwala N
Radiat Oncol 2012 May 23;7:76. doi: 10.1186/1748-717X-7-76. PMID: 22621764Free PMC Article

Clinical prediction guides

Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
Meixner E, Wark A, Forster T, Weykamp F, Lang K, König L, Lindel K, Oelmann-Avendano JT, Krisam J, Schneeweiss A, Ellerbrock M, Mielke T, Hörner-Rieber J, Herfarth K, Debus J, Arians N
Radiat Oncol 2023 Jan 9;18(1):5. doi: 10.1186/s13014-023-02198-4. PMID: 36624483Free PMC Article

Supplemental Content

Table of contents

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...